San Diego, CA, United States of America

Nadejda Valiaeva

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 143(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Nadejda Valiaeva: A Pioneer in Antiviral Drug Development

Introduction

Nadejda Valiaeva is a distinguished inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 20 patents, Valiaeva’s work primarily focuses on antiviral applications, demonstrating a commitment to advancing medical science and public health.

Latest Patents

Valiaeva's recent patents reflect her innovative approach in developing antiviral prodrugs and pharmaceutical formulations. Notable inventions include compounds designed to be orally bioavailable or formulated for intramuscular injection. She has also developed methods for treating coronavirus and other RNA virus infections in mammals. Her research into drug triphosphate production and the use of acyclic nucleotide analogs for managing papillomavirus infections showcases her versatility and depth of knowledge in virology and pharmacology.

Career Highlights

Nadejda Valiaeva has been closely associated with the University of California and The Regents of the University of California, a California Corporation. Her tenure at these institutions has allowed her to push the boundaries of pharmaceutical research, leading to groundbreaking inventions that could change the landscape of antiviral treatments.

Collaborations

Throughout her career, Valiaeva has collaborated with esteemed colleagues such as Karl Y. Hostetler and James R. Beadle. These partnerships illustrate her ability to work within multidisciplinary teams to foster innovation and drive forward-thinking research within the pharmaceutical field.

Conclusion

In summary, Nadejda Valiaeva stands out as a prominent inventor whose contributions to antiviral drug development are noteworthy. Her extensive patent portfolio reflects not only her ingenuity but also her dedication to improving health outcomes through innovative pharmaceutical solutions. As she continues to advance her research, the impact of her work will undoubtedly be felt in medical communities and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…